Long intergenic non-protein coding RNA 1378 (LINC01378)

Long intergenic non-protein coding RNA 1378 (LINC01378, also known as LINC02263) is classified as a long intergenic non-coding RNA (lincRNA). LincRNAs are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and have no or limited protein coding capacity[1][4][7]. There is very limited functional information available for LINC01378 itself, as it does not appear to be a well-characterized or therapeutically targeted molecule. Its role, associations with disease, or utility as a biomarker or drug target have not been established in the available literature. LINC01378 is considered incorrect as a therapeutic target because it is not a classical therapeutic target such as a receptor, enzyme, or transporter, nor is there substantial biological or clinical characterization publicly available as of this review. It is not considered a therapeutic target by current standards and there may be confusion with better-studied lincRNAs (such as LINC01133, which is more extensively characterized in cancer)[2]. The gene is referenced in genomic databases as a non-coding transcript but has not been cited in association with any specific disease, biological pathway, or drug interaction in curated sources[1][4]. No evidence was found for mechanism of action, drug interaction, disease relevance, biomarker status, or safety considerations for this RNA. If more specific or functionally characterized information is needed about non-coding RNA targets, consider querying well-studied lincRNAs (such as LINC01133 or others).

Other names

LINC02263LINC01378[1][4]